Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524374/
https://www.ncbi.nlm.nih.gov/pubmed/26251591
http://dx.doi.org/10.2147/COPD.S82829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524374/
https://www.ncbi.nlm.nih.gov/pubmed/26251591
http://dx.doi.org/10.2147/COPD.S82829

Ejemplares similares